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Simone Amendola1, Martin Plöderl2, Michael P. Hengartner 3,4
1 Department of Dynamic and Clinical Psychology, Faculty of Medicine and Psychology, Sapienza University of Rome,
Rome, Italy
2 Department of Crisis Intervention and Suicide Prevention, Christian Doppler Clinic, Paracelsus Medical University
Salzburg, Salzburg, Austria
3 Department of Applied Psychology, Zurich University of Applied Sciences, Zurich, Switzerland
4 Medical Faculty, University of Zurich, Zurich, Switzerland
Correspondence: Michael P. Hengartner, Department of Applied Psychology, Zurich University of Applied Sciences
(ZHAW), PO Box 707, CH-8037 Zurich, Switzerland, Tel: þ41 (0) 589348382, Fax: þ41 58 934 8439, e-mail:
michaelpascal.hengartner@zhaw.ch
Background: Ecological studies have explored associations between suicide rates and antidepressant prescriptions
in the population, but most of them are limited as they analyzed short-term correlations that may be spurious.
The aim of this long-term study was to examine whether trends in suicide rates changed in three European
countries when the first antidepressants were introduced in 1960 and when prescription rates increased steeply
after 1990 with the introduction of the serotonin reuptake inhibitors (SSRIs). Methods: Data were extracted from
the WHO Mortality Database. Suicide rates were calculated for people aged 10–89 years from 1951–2015 for Italy,
1955–2016 for Austria and 1951–2013 for Switzerland. Trends in suicide rates stratified by gender were analyzed
using joinpoint regression models. Results: There was a general pattern of long-term trends that was broadly
consistent across all three countries. Suicide rates were stable or decreasing during the 1950s and 1960s, they rose
during the 1970s, peaked in the early 1980s and thereafter they declined. There were a few notable exceptions to
these general trends. In Italian men, suicide rates increased until 1997, then fell sharply until 2006 and increased
again from 2006 to 2015. In women from all three countries, there was an extended period during the 2000s when
suicide rates were stable. No trend changes occurred around 1960 or 1990. Conclusions: The introduction of
antidepressants around 1960 and the sharp increase in prescriptions after 1990 with the introduction of the
SSRIs did not coincide with trend changes in suicide rates in Italy, Austria or Switzerland.
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Introduction
There is ongoing debate about the impact of antidepressant use onthe risk of suicide, at both the individual level and the population
level.1,2 Meta-analyses of clinical trials have found either no definite
association between antidepressant use and risk of (attempted) sui-
cide or significantly increased risk.3–7 Observational studies likewise
produced inconsistent results. An older meta-analysis of case–con-
trol and cohort studies found increased suicide risk with selective
serotonin reuptake inhibitors (SSRIs) in paediatric patients with
depression and significantly reduced risk in adult patients.8 An
updated and expanded meta-analysis found no definite association
between SSRIs and suicide risk in adult patients with depression but
significantly increased risk with any new-generation antidepressant
in adult patients with depression and other treatment indications.9
Nevertheless, based on the findings from ecological studies, vari-
ous authors have concluded that the increased prescription of SSRIs
and other new-generation antidepressants has likely contributed to
lower suicide rates in the population.2,10,11 Such strong claims are
not firmly supported by the evidence though, as the results of eco-
logical studies are inconsistent. Some studies have found negative
correlations between antidepressant prescriptions and suicide rates,
some no association, and yet others even positive correlations.12–14
However, on the population level, a disease can be highly correlated
with an environmental variable even when on an individual level
they are unrelated or show an association in the opposite direction,
a methodological bias long known as the ecological fallacy.15 This
bias occurs when the background rate of a disease varies across
groups, e.g. different socioeconomic strata.
In one of the most rigorously conducted ecological studies,
Dahlberg and Lundin16 showed a negative and statistically highly
significant correlation between antidepressant prescriptions and the
suicide rate between 1990 and 2000 in Sweden when other variables
where not controlled for. By contrast, when they controlled for
socioeconomic factors, the correlation between suicides and antide-
pressants was no longer negative and statistically non-significant.16
Complicating matters further, most ecological studies have corre-
lated antidepressant prescriptions and suicide rates over a relatively
short time-period, commonly between around 1990 and the early
2000s,11,12 even though antidepressants have been used in clinical
practice since about 1960. Suicide rates can fluctuate widely over
decades due to various socioeconomic and cultural factors.17–19
Therefore, restricting the analysis to a short time-period, e.g.
1990–2000, may easily produce spurious correlations, even when
known confounders, such as unemployment and alcohol consump-
tion, are statistically controlled for.20
The aim of this study was to analyze long-term trends in suicide
rates in Italy, Switzerland and Austria. These three countries were
chosen as they are the countries of origin of the study authors and
appropriate long-term suicide data were available. Moreover, the
three countries have similar healthcare systems (statutory health
insurance; general practitioners act as gatekeepers), but otherwise
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differ culturally (Italy is a Mediterranean Latin country, Austria an
Alpine Germanic country and Switzerland a mixed Latin-Germanic
country). To avoid the methodological biases detailed above, we did
not compute correlations between suicide rates and antidepressant
prescriptions, but examined whether the introduction of the first
antidepressants in clinical practice around 196021 and the steep in-
crease in prescriptions after 1990 with the introduction of the SSRIs
and other new-generation antidepressants11 would relate to sus-
tained changes in long-term trends in suicide rates. As outlined by
Stone,22 reductions in suicide rates should mostly occur when new
antidepressants are first introduced into a population, but there will
be much less reduction as use spreads. As a result, assuming anti-
depressant prescriptions had a clear and sustained suicide-protective
effect at the population level, we would expect (i) a decrease in
suicide rates around 1960 when the first antidepressants were intro-
duced and (ii) another decrease starting 1990 when the SSRIs were
introduced.
Methods
Data sources
Suicide deaths among people aged 10–89 years in Italy, Austria and
Switzerland were examined. The annual data on suicides were
extracted in March 2020 from the WHO Mortality Database
(https://apps.who.int/healthinfo/statistics/mortality/causeofdeath_
query/start.php) for the periods 1951–2015 for Italy (64 years),
1955–2016 for Austria (61 years) and 1951–2013 for Switzerland
(62 years), overall and stratified by gender. Suicide as a cause of
death was recorded according to the seventh (code A148, suicide
and self-inflicted injury), eighth (code A147, suicide and self-
inflicted injury), ninth (codes E950–E959, suicide and self-inflicted
injury) and tenth (codes X60–X84, intentional self-harm) revision of
the International Classification of Diseases. Based on the literature,
we set the time point for the introduction of the first antidepressants
in clinical practice around 196021,23 and the introduction of the
SSRIs that prompted a steep and mostly ongoing increase in anti-
depressant prescriptions in Europe and elsewhere as of 1990.11,24,25
According to Swiss law, the study was exempt of approval by an
ethics committee because all data were de-identified and publicly
available.
Statistical analysis
Suicide rates were calculated as the annual number of suicides per
100 000 individuals (age range 10–89 years), overall and by gender.
Trends in suicide rates were analyzed using the Joinpoint Regression
Program, version 4.8.0.1, from the US National Cancer Institute.26
Joinpoints were determined separately by gender. These models
were used to estimate the average annual percent change (APC) in
suicide rates and the number and location of joinpoints, based on
linear regression with the log suicide rates as the dependent variable
and the year as the independent variable. The regression model
assumed that the random errors followed a Poisson distribution
and the regression coefficients were estimated by weighted least
squares.26 Joinpoint regression performs multiple tests in order to
select the number of joinpoints using permutation test and choosing
the model with the best fit to the data.27 In the final model, join-
points indicate the points in time when changes in long-term trends
occur. The APC, based on the slope of the line segment, describes an
increasing trend (positive APC value) or decreasing trend (negative
APC value).
Results
Suicide rates
A total of 241 708 people (175 473 males; 66 235 females) died by
suicide in Italy between 1951 and 2015; 101 896 suicides (72 136
males; 29 760 females) were recorded in Austria between 1955 and
2016; and 79 876 suicides (56 611 males; 23 265 females) were
recorded in Switzerland between 1951 and 2013. The average rates
(per 100 000) across the entire observation period were 7.7 in Italy
(males: 11.5; females: 4.1), 24.8 in Austria (males: 37.2; females:
13.8) and 23.8 in Switzerland (males: 33.7; females: 12.9). The
results of the joinpoint analyses for each country, stratified by gen-
der, are reported in table 1 and the long-term trends in suicide rates
are shown in figures 1–3.
Trends in suicide rates—Italy
Four joinpoints were detected for each gender as depicted in figure 1.
Among males, there was a significantly decreasing trend in suicide
rates between 1951 and 1974 by 1.0% per year. Afterwards, the curve
sharply rose by 4.2% per year until 1982 and thereafter it slightly
increased by 0.7% per year until 1997. Between 1997 and 2006, a
decrease of 2.5% per year was observed. Starting in 2006, a new
upturn by 1.3% per year occurred until 2015. Among females, the
suicide rate was stable between 1951 and 1957, then the suicide rate
decreased by 2.7% per year until 1965. A new increase of 1.8% per
year was recorded between 1965 and 1985. Afterwards, a decrease of
2.1% per year was reported from 1985 to 2009. Lastly, from 2009 to
2015, the rate remained stable. No decreasing trend in suicide rates
began coincident with the introduction of the first antidepressants
in 1960 or with the introduction and widespread prescription of
SSRIs beginning 1990.
Trends in suicide rates—Austria
As shown in figure 2, two joinpoints were found for both males and
females. The shape of the trends was similar across gender. In males,
the suicide rate was constant between 1955 and 1976, afterwards
suicide rates increased until 1984 by 2.1% per year and then
decreased by 2.2% per year until 2016. In females, the suicide rate
was constant between 1955 and 1987, then the rate considerably
Table 1 APC in suicide rates in males and females according to
joinpoint regression models
Country Population Period APC (95% CI)
Italy M 1951–74 1.0 (1.4 to 0.7)
M 1974–82 4.2 (2.2–6.3)
M 1982–97 0.7 (0.1–1.3)
M 1997–2006 2.5 (3.9 to 1.1)
M 2006–15 1.3 (0.1–2.5)
F 1951–57 1.2 (1.2 to 3.7)
F 1957–65 2.7 (4.6 to 0.9)
F 1965–85 1.8 (1.4–2.2)
F 1985–2009 2.1 (2.4 to 1.9)
F 2009–15 0.6 (1.8 to 3.1)
Austria M 1955–76 0.1 (0.2 to 0.4)
M 1976–84 2.1 (0.7–3.6)
M 1984–2016 2.2 (2.4 to 2.1)
F 1955–87 0.0 (0.2 to 0.2)
F 1987–2008 3.6 (4.0 to 3.1)
F 2008–16 0.7 (2.7 to 1.3)
Switzerland M 1951–68 1.8 (2.3 to 1.4)
M 1968–80 2.7 (1.8–3.6)
M 1980–94 1.2 (1.8 to 0.6)
M 1994–2013 2.7 (3.0 to 2.3)
F 1951–68 1.3 (2.1 to 0.6)
F 1968–79 4.2 (2.6–5.7)
F 1979–98 2.1 (2.6 to 1.5)
F 1998–2008 0.3 (1.7 to 2.4)
F 2008–13 9.4 (12.5 to 6.2)a
a: Joinpoint is a methodological artefact due to change in reporting
methods (for details, see Junker28).
M, males; F, females; APC, annual percent change; CI, confidence
interval.
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decreased by 3.6% per year until 2008. From 2008 to 2016, the
suicide rate was again constant. No decreasing trend in suicide rates
began coincident with the introduction of the first antidepressants
in 1960 or with the introduction and widespread prescription of
SSRIs beginning 1990.
Trends in suicide rates—Switzerland
As depicted in figure 3, joinpoint analyses indicated three joinpoints
for males and four for females. In men, a decrease in suicide rates of
1.8% per year was detected between 1951 and 1968. Afterwards, the
rates sharply rose by 2.7% per year until 1980. Between 1980 and
1994, the suicide rates slightly decreased by 1.2% per year and from
1994 to 2013, they fell by 2.7% per year. In women, the suicide rate
fell slightly by 1.3% per year between 1951 and 1968. Afterwards
there was a steep increase by 4.2% per year until 1979. From 1979 to
1998, the rates decreased again by 2.1% per year, thereafter they
remained stable until 2008. From 2008 to 2013, the rates fell sharply
by 9.4% per year.
Figure 1 Suicide trends among males and females aged 10–89 years in Italy, 1951–2015
Dots, male suicide rate; Triangles, female suicide rate. The two bold vertical lines denote the time points when the first antidepressants
were introduced (1960) and when the SSRIs were introduced and widespread prescription began (1990).
Figure 2 Suicide trends among males and females aged 10–89 years in Austria, 1955–2016
Dots, male suicide rate; Triangles, female suicide rate. The two bold vertical lines denote the time points when the first antidepressants
were introduced (1960) and when the SSRIs were introduced and widespread prescription began (1990).
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However, the abrupt drop in suicide rates after 2008 is a meth-
odological artefact due to a change in reporting methods28; as of
2009 physician-assisted suicides were no longer included in the
Swiss suicide statistics. In fact, the stable trend starting in 1998
did not end in 2008 but continued until 2013 had the reporting
methods not changed. Suicide data published by the Swiss Federal
Statistical Office28 reveal that the female suicide rate was constant,
or by tendency even slightly increasing from 2008 to 2014 when
physician-assisted suicides were included in the statistic (rates per
100 000 varying between 12 and 14). As in Italy and Austria, no
decreasing trend in suicide rates began coincident with the intro-
duction of the first antidepressants in 1960 or with the introduction
and widespread prescription of SSRIs beginning 1990.
Post-hoc analysis
As requested during the review process, we conducted an analysis
restricted to people aged 10–24 years, as various studies indicate that
new-generation antidepressants increase the risk of suicidal events in
youth and young adults, which also lead to a respective regulatory
safety warning.6–8,29 The changes in long-term trends in suicide rates
in people aged 10–24 years, stratified by gender, were very similar to
the trends reported above for people aged 10–89 years. That is, there
was no evidence that the introduction of first- or new-generation
antidepressants led to sustained changes in suicide rates in people
aged 10–24 years. The results of the joinpoint regression analyses for
adolescents and young adults are shown in the Supplementary
material.
Discussion
Our analysis of long-term trends in suicide rates in people aged 10–
89 years in Italy, Austria and Switzerland from about 1950–2015
revealed one major pattern that was largely consistent across coun-
tries and gender. Suicide rates were stable or decreasing during the
1950s and 1960s, then they rose during the 1970s, peaked in the
early 1980s and thereafter they were mostly declining. However,
there were a few notable gender-specific exceptions to these general
trends. First, in Italian men, the suicide rates were increasing far
beyond the 1980s and peaked only in 1997, thereafter they fell sharp-
ly until 2006 but increased again from 2006 to 2015. Second, in
women from all three countries there was an extended period during
the 2000s when suicide rates were stable. In Italian women, the
suicide rates were constant from 2009 to 2015, in Austrian women,
they were constant from 2008 to 2016 and in Swiss women, the
suicide rates were constant between 1998 and 2013 (after correcting
for a change in suicide reporting methods28). A post-hoc analysis
restricted to adolescents and young adults aged 10–24 years pro-
duced comparable results.
Most importantly, the introduction of the first antidepressants
around 1960 and the introduction of the SSRIs in 1990 that caused
a steep increase in antidepressant prescriptions did not coincide
with changes in trends of suicide rates in any country. Except for
Italian men, whose suicide rates were increasing from 1974 to 1997,
suicide rates were constantly declining long before antidepressant
prescriptions sharply rose between 1990 and 2010.11 This general
pattern is consistent with the findings from many other countries
where negative correlations between suicide rates and antidepressant
prescriptions were observed during the 1990s.14,25 Moreover, female
suicide rates were stable over extended periods during the 2000s,
despite unabated increases in antidepressant prescriptions during
that period.11,30 These findings are consistent with long-term studies
from various other countries that do not indicate that the introduc-
tion of the first antidepressants in 1960 and widespread prescription
of antidepressants after the introduction of the SSRIs in 1990 had
led to clear and sustained changes in suicide rates.17–19 Our results
also agree with two systematic reviews of ecological studies, which
concluded that the evidence does provide limited or no support for
the hypothesis that increased antidepressant prescriptions led to
reduced suicide rates in the population.12,14 Likewise, in adolescents
and young adults aged 10–24 years there was not a consistent pattern
that would indicate that the introduction of the SSRIs led to an
increase in suicide rates on the population level in Italy, Austria
or Switzerland.
Figure 3 Suicide trends among males and females aged 10–89 years in Switzerland, 1951–2013
Dots, male suicide rate; Triangles, Female suicide rate. The two bold vertical lines denote the time points when the first antidepressants
were introduced (1960) and when the SSRIs were introduced and widespread prescription began (1990). The last joinpoint in females is a
methodological artefact due to change in reporting methods (for details, see Junker28).
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Our findings conflict with the ecological study by Gusmao et al.11
who concluded that ‘These findings underline the importance of the
appropriate use of antidepressants as part of routine care for people
diagnosed with depression, therefore reducing the risk of suicide’ (p.
1). Although Gusmao et al.11 found strong negative correlations
between antidepressant prescriptions and suicide rates across 29
European countries, the authors dismissed the evidence that in al-
most all countries the suicide rates were constantly falling long be-
fore antidepressant prescriptions exploded during the 1990s due to
the introduction of the SSRIs.
Temporality is an essential premise of cause-effect relationships
and refers to the necessity for a cause to precede an effect in time.31
Given that the decline in suicide rates beginning around 1980 in
most countries (the putative effect) preceded the rise in antidepres-
sant prescriptions after 1990 (the putative cause), logic dictates that
antidepressant prescription cannot be the cause of the declining
suicide rates during that period. Claiming otherwise is a logical fal-
lacy, and this has been pointed out for many years by various
researchers12,14,25 but seems not to have received proper recognition.
To the contrary, in a rather fallacious argumentation, Gusmao
et al.11 interpreted the declining suicide rates during the 1980s as
evidence that this was an effect of first-generation antidepressant
prescriptions:
‘Antidepressant utilization DDD/1000/day increase had an im-
portant effect in suicide SDR from the start, when suicide SDR
started to lower in Europe. This rebuffs most criticisms and scep-
ticism on observable antidepressant effects on suicide decrease,
usually stating that suicide had already started to decrease before
antidepressant utilization exploded, in the nineties, therefore
denying earlier generation antidepressant effects’ (p. 11).
Gusmao et al.11 obviously ignored the fact that, for the few coun-
tries for which data on antidepressant use were available for the
1980s (only 5 of the 29 countries studied), the prescription rates
were largely stable (Denmark and Czech Republic) or at best mar-
ginally increasing at low levels (Sweden, Norway and Finland).
During the 1990s, after the introduction of the SSRIs, antidepressant
use abruptly increased many times over without a discernible change
in long-term trends of suicide in virtually all 29 countries (see their
Figures 1–4). Moreover, since Gusmao et al.11 examined suicide
rates only as of 1980, and not ‘from the start’ of the antidepressant
treatment era, their analysis did not show that the suicide rates
constantly increased during the 1970s in many European countries,
as demonstrated by our data for Italy, Austria and Switzerland, but
also in many other countries, e.g. Norway, Denmark and Finland.25
This general pattern invalidates the interpretation by Gusmao et al.11
that the first-generation antidepressants introduced in 1960 and the
SSRIs introduced in 1990 had led to declining suicide rates. If first-
generation antidepressants were responsible for the declining suicide
rates during the 1980s, then, by the authors’ own logic, they would
also be responsible for the increasing suicide rates during the 1970s.
Another instructive illustration comes from the USA, where
declining suicide rates between 1985 and 1999 were correlated
with increasing rates of antidepressant prescriptions.10 But while
antidepressant prescriptions continued to rise during the 2000s
and 2010s,32,33 there was a sudden trend change in suicide rates in
2000, after which the suicide rates were constantly rising in almost
all age groups.34,35 This indicates that the negative correlation be-
tween suicide rates and antidepressant prescriptions observed be-
tween 1985 and 199910 was spurious, unless the authors accept
that since 2000 the ever-increasing use of antidepressants has caused
a constant surge of suicides in the USA.
Therefore, we want to emphasize again how important it is to
examine long-term suicide trends and to focus on the time points
when antidepressants were introduced in clinical practice, instead of
computing correlations between the two variables over a short time-
frame. Relating suicide rates to antidepressant prescriptions over a
selectively chosen short time-period can easily produce spurious
correlations that lead authors to erroneous conclusions.22,36,37 We
also want to stress that ecological studies have limited validity for
assessing the effectiveness and safety of antidepressants on an indi-
vidual level. The most accurate method to evaluate the benefit-risk
profile of antidepressants is the clinical trial, followed by well-
controlled prospective cohort studies. The results of ecological stud-
ies may help to elucidate whether antidepressants have discernible
public health effects, but they must be interpreted with caution.
They can neither prove nor disconfirm that antidepressants alter
the suicide risk, a serious limitation that was not sufficiently
acknowledged by various authors.2,22,36
This study has several limitations. First, due to its ecological de-
sign, the data capture only suicides at the population level and are
restricted to Italy, Austria and Switzerland. The results do not ne-
cessarily generalize to other countries, although in the discussion, we
emphasize similarities to various other European countries, e.g.
Norway, Denmark and Finland. Second, which deaths are recorded,
classified and reported as suicides may differ between countries and
different time periods within countries. For instance, there is a
strong correlation between autopsy rates and official suicide rates,
both between and within countries, suggesting that a reduction in
autopsy rates may result in misclassifications of causes of death.38
Third, the time points we set for the introduction of the first anti-
depressants in clinical practice (1960) and the sharp increase of
prescriptions following the introduction of the SSRIs (1990) may
slightly vary between countries. For instance, in Italy the increase of
antidepressant prescriptions was rather modest during the early
1990s, but much steeper during the early 2000s.11,24 However, this
does not alter the interpretation of our results. The nearest join-
points following the introduction and widespread prescription of
SSRIs that mark the beginning of a decreasing trend in suicide rates
were 1994 in Swiss males and 1997 in Italian males (fluoxetine, the
SSRI marking a new treatment era, was introduced 1991 in
Switzerland and 1989 in Italy). Moreover, no changes in trends
following the introduction of the SSRIs were found in Italian and
Swiss females, in whom the rate of antidepressant use is about two
times higher than in males.39,40
In conclusion, this ecological study of long-term suicide trends
in Italy, Austria and Switzerland did not find evidence that the
introduction of the first antidepressants in clinical practice around
1960 and the introduction of the SSRIs in 1990 that led to steep
increases in prescription rates coincided with a sustained trend
change in suicide rates. Except for Italian males, suicide rates
were constantly declining long before antidepressant prescription
rates multiplied during the 1990s, thus violating the basic premise
of temporality in cause–effect relationships.31 These findings indi-
cate that at the population level, the evidence does not support the
popular claim that the increased use of antidepressants has con-
tributed to a significant decline in suicide rates.2 Ecological studies
cannot indicate cause–effect relationship and may have serious
flaws,2,22,36 but if well conducted and cautiously interpreted they
may provide valuable insights for public health. This was not al-
ways the case with ecological studies on the association between
antidepressant use and suicide rates, which often focussed on
selected short-term periods while neglecting long-term
trends.2,14,22,35
Supplementary data
Supplementary data are available at EURPUB online.
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Key points
• Ecological analyses restricted to short-term trends of suicide
rates are often misleading.
• Long-term trends of suicide rates in the population may help
to elucidate whether the introduction of antidepressants had
discernible public health effects.
• Trends in suicide rates from about 1950 to 2015 in Italy,
Austria and Switzerland are broadly comparable.
• With a few gender-specific exceptions, the suicide rates were
stable or declining during the 1950s and 1960s, increased dur-
ing the 1970s, peaked in the early 1980s and declined
thereafter.
• No change in suicide trends occurred around 1960, when the
first antidepressants were introduced in clinical practice or
after 1990, when antidepressant prescriptions steeply rose
with the introduction of the selective serotonin reuptake
inhibitors.
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